1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South & Central America Organoids Services Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South & Central America Organoids Services Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South & Central America Organoids Services Market Regional Analysis
6.2 South & Central America Organoids Services Market Revenue 2021-2031 (US$ Million)
6.3 South & Central America Organoids Services Market Forecast Analysis
7. South & Central America Organoids Services Market Analysis – by Type
7.1 Intestine
- 7.1.1 Overview
- 7.1.2 Intestine: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Liver
- 7.2.1 Overview
- 7.2.2 Liver: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Stomach
- 7.3.1 Overview
- 7.3.2 Stomach: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Pancreas
- 7.4.1 Overview
- 7.4.2 Pancreas: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Lung
- 7.5.1 Overview
- 7.5.2 Lung: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Brain
- 7.6.1 Overview
- 7.6.2 Brain: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.7 Kidney
- 7.7.1 Overview
- 7.7.2 Kidney: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. South & Central America Organoids Services Market Analysis – by Application
8.1 Developmental Biology Disease
- 8.1.1 Overview
- 8.1.2 Developmental Biology Disease: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Pathology of Infectious Disease
- 8.2.1 Overview
- 8.2.2 Pathology of Infectious Disease: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Regenerative Medicine
- 8.3.1 Overview
- 8.3.2 Regenerative Medicine: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Drug Toxicity & Efficacy Testing
- 8.4.1 Overview
- 8.4.2 Drug Toxicity & Efficacy Testing: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Drug Discovery & Personalized Medicine
- 8.5.1 Overview
- 8.5.2 Drug Discovery & Personalized Medicine: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. South & Central America Organoids Services Market Analysis – by Source
9.1 Pluripotent Stem Cells
- 9.1.1 Overview
- 9.1.2 Pluripotent Stem Cells: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Organ Specific Adult Stem Cell
- 9.2.1 Overview
- 9.2.2 Organ Specific Adult Stem Cell: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. South & Central America Organoids Services Market – South and Central America Analysis
10.1 Overview
10.2 South and Central America
- 10.2.1 South & Central America Organoids Services Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 10.2.1.1 South & Central America Organoids Services Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Brazil:
South & Central America Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 Brazil: South & Central America Organoids Services Market Breakdown, by Type
- 10.2.1.1.2 Brazil: South & Central America Organoids Services Market Breakdown, by Application
- 10.2.1.1.3 Brazil: South & Central America Organoids Services Market Breakdown, by Source
- 10.2.1.2 Argentina:
South & Central America Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Argentina: South & Central America Organoids Services Market Breakdown, by Type
- 10.2.1.2.2 Argentina: South & Central America Organoids Services Market Breakdown, by Application
- 10.2.1.2.3 Argentina: South & Central America Organoids Services Market Breakdown, by Source
- 10.2.1.3 Rest of South and Central America:
South & Central America Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Rest of South and Central America: South & Central America Organoids Services Market Breakdown, by Type
- 10.2.1.3.2 Rest of South and Central America: South & Central America Organoids Services Market Breakdown, by Application
- 10.2.1.3.3 Rest of South and Central America: South & Central America Organoids Services Market Breakdown, by Source
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 CUSABIO TECHNOLOGY LLC
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Cyprio
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Eurofins Scientific SE
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 HUB Organoids B.V. (Hubrecht Organoid Technology)
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 InnoSer
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 InSphero
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 LABTOO
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Molecular Devices, LLC.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Oncodesign Services
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Sino Biological Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations